戻る Agenda
Session 8 - Clinical Trial Facility Cost
Session Chair(s)
Keiichi Inaizumi, MSc
Clinical Project Management Group/ Japan Clinical Project Manager
Pfizer R&D Japan, Japan
Toshiko Ishibashi, PhD, RN
Oncology Medical Science Department, Medical Affairs Division
Daiichi Sankyo Co., Ltd., Japan
S8-3
Speaker(s)
S8-1
Masayuki Moue
Janssen Pharmaceutical K.K., Japan
Local Trial Manager(CRA), Trial Operation Dept.
S8-2
Masaki Higashi
AbbVie GK, Japan
Associate Clinical Operations Manager
Keiichi Inaizumi, MSc
Pfizer R&D Japan, Japan
Clinical Project Management Group/ Japan Clinical Project Manager
Yutaka Sato
Medidata Solutions K.K., Japan
Manager, Presales
Rintaro Takeya
Tata Consultancy Services Japan, Japan
Delivery Manager, Life Sciences Cluster
Noriko Morishita, MSN
National Hospital Organization Headquarters, Japan
Manager, Clinical Trial Promotion Office
Komei Shimokawa
National Center of Neurology and Psychiatry (NCNP), Japan
Department of Pharmacy
Masahiko Ozaki, MS
National Cancer Center Hospital East, Japan
Manager, Ethical Review Support Section